Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
DNA Immunization
100%
Cytotoxic T-Cell
75%
Antigen
45%
Antigen Specificity
44%
Immune Response
44%
Human Papillomavirus Type 16
42%
Vaccine Efficacy
40%
Wart Virus
39%
Calreticulin
26%
Dendritic Cell
26%
T Cell
23%
DNA Vaccination
22%
Infection
21%
Peptides
20%
Infectious Disease
20%
Immunotherapy
20%
Tumor Cell
17%
Epitope
16%
Cancer Immunotherapy
16%
Tumor Antigen
16%
Adoptive Immunity
13%
T-Helper Cell
13%
Adaptive Immune System
9%
C57BL 6 Mouse
8%
Heat Shock
8%
CD8
8%
Electroporation
8%
MHC Class I
8%
Cytotoxic T Cell
8%
Interleukin 2
8%
CD4
8%
Ribonucleic Acid
8%
Vaccinium
7%
Antigen Presentation
7%
Mouse Model
6%
Mycobacterium Tuberculosis
6%
Immune Tolerance
6%
Albumin
6%
In Vitro
6%
Tumor Vaccine
6%
Cervarix
6%
Natural Killer Cell
6%
Cancer Cell
6%
Vaccinia Virus
6%
HPV Vaccine
5%
Wild Type
5%
Transgenic Mouse
5%
Virus
5%
interferon
5%
Papillomaviridae
5%
Keyphrases
DNA Vaccine
73%
Tumor
47%
Antitumor Effect
41%
Human Papillomavirus
40%
CD8+
39%
HPV16
38%
Vaccine Potency
35%
Vaccination
26%
Calreticulin
26%
DNA Vaccination
25%
Tumor Immunity
22%
T Cell Immune Response
22%
CD8+ T Cells
22%
Dendritic Cells
21%
Antigen-specific
19%
Ovarian Cancer
18%
Cervical Cancer
18%
Human Papillomavirus Vaccine
17%
Cancer Immunotherapy
16%
Tumor Cells
14%
Human Papillomavirus DNA
12%
DNA Encoding
12%
Tumor Antigen
12%
T Cells
11%
CD4+ T
11%
Electroporation
10%
Vaccine Target
10%
T-cell Mediated
10%
Heat Shock Protein 70 (HSP70)
9%
Vaccinium
9%
Papillomavirus Infections
9%
HPV16 E7
8%
Immune Response
8%
E7 Antigen
8%
HPV DNA Vaccine
8%
Antigen-specific CD8+ T Cells
7%
Tumor Microenvironment
7%
Response Effects
7%
TC-1 Tumor
7%
Interleukin-2
7%
Tumor-bearing Mice
7%
C57BL
7%
T Cell Response
6%
Ovarian Tumor
6%
Therapeutic Effect
6%
Lysosome-associated Membrane Protein 1 (LAMP1)
6%
Antigenic Genes
6%
Cervicovaginal
6%
Tumor Model
5%
Tumor Growth
5%
Pharmacology, Toxicology and Pharmaceutical Science
DNA Immunization
34%
Human Papillomavirus
32%
Neoplasm
28%
CD8 Antigen
21%
Antigen
21%
Malignant Neoplasm
21%
Human Papillomavirus Type 16
16%
Vaccination
16%
Wart Virus Vaccine
16%
Ovary Cancer
15%
Uterine Cervix Cancer
14%
Calreticulin
10%
Immunotherapy
10%
Diseases
10%
Infection
8%
Chemotherapy Regimens
6%
Papillomavirus Infection
6%
Cisplatin
6%
Therapeutic Effect
6%
Peptide
5%
Ovary Tumor
5%